Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Saint Louis University School of MedicineClass of 2000
Clinical Trials
- Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects Start of enrollment: 2020 Jul 01
Publications & Presentations
PubMed
- 11 citationsGnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, Yunfei Wen, Emine Bayraktar
Molecular Cancer Therapeutics. 2019-05-01 - 22 citationsPRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian CancerTakeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep
Molecular Cancer Therapeutics. 2019-01-01 - 149 citationsFABP4 as a key determinant of metastatic potential of ovarian cancerKshipra M. Gharpure, Sunila Pradeep, Marta Sans, Rajesha Rupaimoole, Cristina Ivan
Nature Communications. 2018-07-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
